Skip to main content
Equibles

BARCLAYS PLC

Position in EDIT — Editas Medicine, Inc.

CIK 312069 LONDON, X0
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$483,614
+$123,978 QoQ
Shares Held
149,264
+2.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. EDIT ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $483,614 149,264
2026-03-31 $359,636 145,602
2025-12-31 $566,336 276,262
2025-09-30 $649,063 187,050
2025-06-30 $438,966 199,530
2025-03-31 $163,773 141,184
2024-12-31 $230,171 181,238
2024-09-30 $608,708 178,507
2024-06-30 $567,502 121,521
2024-03-31 $1,073,843 144,723
2023-12-31 $2,830,049 279,437
2023-09-30 $2,145,124 275,016
2023-06-30 $2,463,123 299,286
2023-03-31 $1,993,207 275,122
2022-12-31 $3,905,790 440,401
2022-09-30 $3,674,778 300,227
2022-06-30 $260,484 22,019
2022-03-31 $595,934 31,332
2021-12-31 $2,508,814 94,494
2021-09-30 $3,727,557 90,739
2021-06-30 $3,601,963 63,594
2021-03-31 $4,389,714 104,517
2020-12-31 $1,673,174 23,865
2020-09-30 $1,317,641 46,958
2020-06-30 $1,506,538 50,931
2020-03-31 $894,550 45,111